| Cd20 binding molecules and uses thereof |
2022-11-07 |
2023-1-01 |
|
| Use of a multimeric anti-dr5 binding molecule in combination with a cancer … |
2022-10-25 |
2022-12-01 |
|
| Pd-1 agonist multimeric binding molecules |
2022-10-03 |
2022-12-01 |
|
| Tumor necrosis factor (tnf) superfamily receptor-binding molecules and uses … |
2022-9-07 |
2022-11-30 |
|
| Multimeric coronavirus binding molecules and uses thereof |
2022-7-14 |
2022-12-22 |
|
| Modified human igm constant regions for modulation of complement-dependent … |
2022-6-10 |
2022-10-27 |
|
| Highly sialylated multimeric binding molecules |
2022-6-09 |
2022-8-01 |
|
| Binding molecule with modified j chain |
2022-4-26 |
2022-7-12 |
|
| Modified j-chain |
2022-4-17 |
2022-6-01 |
|
| Multimeric antibodies with enhanced selectivity for cells with high target … |
2022-3-14 |
2022-5-01 |
|
| Multimeric gitr binding molecules and uses thereof |
2022-2-24 |
2022-6-09 |
|
| Anti-cd123 binding molecules and uses thereof |
2022-2-17 |
2022-8-25 |
|
| Multimeric ox40 binding molecules and uses thereof |
2022-2-17 |
2022-6-02 |
|
| Multimeric sars-cov-2 binding molecules and uses thereof |
2022-2-15 |
2022-8-25 |
|
| Igm glycovariants |
2022-1-31 |
2022-4-01 |
|
| Multimeric bispecific anti-cd123 binding molecules and uses thereof |
2022-1-19 |
2022-3-01 |
|
| Immunostimulatory multimeric binding molecules |
2022-1-16 |
2022-3-01 |
|
| Multimeric cd40 binding molecules and uses thereof |
2021-12-17 |
2022-4-07 |
|
| Uses of effector cell engaging molecules with moieties of differing potencies |
2021-11-17 |
2022-5-27 |
|
| Multimeric cd137/4-1bb binding molecules and uses thereof |
2021-8-17 |
2021-12-16 |
|
| Multivalent igm- and iga-fc-based binding molecules |
2021-3-30 |
2021-5-31 |
|
| Anti-pd-l1 antibodies |
2021-2-10 |
2021-6-03 |
|
| IgM Fc AND J-CHAIN MUTATIONS THAT AFFECT IgM SERUM HALF-LIFE |
2020-12-03 |
2021-3-25 |
|
| Multi-valent hepatitis b virus antigen binding molecules and uses thereof |
2020-2-19 |
2021-1-07 |
|
| Anti-gitr antigen-binding domains and uses thereof |
2020-2-06 |
2020-8-13 |
|
| Multi-valent human immunodeficiency virus antigen binding molecules and uses … |
2020-1-07 |
2020-12-03 |
|
| Use of a multimeric anti-dr5 binding molecule in combination with a … |
2019-2-25 |
2021-12-29 |
|
| BINDING MOLECULES WITH MODIFIED J-CHAIN |
2016-9-30 |
2020-9-07 |
2020-9-07 |
| Cdim binding proteins and uses thereof |
2015-8-05 |
2015-8-27 |
|
| Cdim binding proteins and uses thereof cdim |
2015-6-09 |
2015-12-11 |
|
| IGA MULTI-SPECIFIC BINDING MOLECULES |
2015-2-10 |
2018-6-12 |
|
| Iga multi-specific binding molecules |
2015-2-10 |
2023-4-04 |
2023-4-04 |
| Constant chain modified bispecific, penta- and hexavalent ig-m antibodies |
2014-9-04 |
2015-4-16 |
|
| Antibody induced cell membrane wounding |
2013-2-19 |
2016-10-04 |
2016-10-04 |
| Treatment of B-cell disease using anti-germline antibody binders |
2006-9-19 |
2009-3-05 |
|
| Enhanced b cell cytotoxicity of cdim binding antibody |
2004-11-05 |
2005-5-19 |
|
| Molecules de liaison multispecifiques iga |
2015-2-10 |
2023-4-04 |
2023-4-04 |